https://www.selleckchem.com/pr....oducts/sitagliptin.h
Infantile leukemia encompasses a heterogeneous group which needs stratifying for treatment selection. We collected 78 cases of infantile leukemia and retrospectively analyzed their clinicopathological data. Infantile leukemia featured a ratio of acute myeloid leukemia (AML) to B-lymphoblastic leukemia (B-ALL) of 12, with a better survival for AML than B-ALL (median survival 36 vs 24 months). When stratified by age, "early" infantile B-ALL (2-6 months) showed a high rate of KMT2A rearrangement (100%), similar to the rate seen in cong
Aimer
Commentaire
Partagez
